Search Ontology:
ChEBI
emtricitabine
- Term ID
- CHEBI:31536
- Synonyms
-
- (-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
- (-)-2'-deoxy-5-fluoro-3'-thiacytidine
- (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine
- (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
- (-)-FTC
- (2R-cis)-4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
- 4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
- 4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one
- 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
- 5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
- EMTRICITABINE
- Definition
- An organofluorine compound that is 5-fluorocytosine substituted at the 1 position by a 2-(hydroxymethyl)-1,3-oxathiolan-5-yl group (2R,5S configuration). It is used in combination therapy for the treatment of HIV-1 infection.
- References
-
- beilstein:5908714
- cas:143491-57-0
- drugbank:DB00879
- drugcentral:1003
- kegg.compound:C12599
- kegg.drug:D01199
- patent:US5538975
- patent:WO9214743
- pdb-ccd:ETV
- pubmed:11491420
- pubmed:14609348
- pubmed:14693538
- pubmed:15206508
- pubmed:15249567
- pubmed:15588339
- pubmed:15875341
- pubmed:15977972
- pubmed:16034488
- pubmed:16323102
- pubmed:16401810
- pubmed:17526857
- pubmed:19493710
- pubmed:22915463
- pubmed:22917277
- pubmed:22935078
- pubmed:23337366
- pubmed:23361642
- pubmed:25017682
- wikipedia.en:Emtricitabine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from emtricitabine
Phenotype where environments contain emtricitabine
Phenotype modified by environments containing emtricitabine
Phenotype affecting emtricitabine
Human Disease Model